HCA

HCA Healthcare Inc.

Price

$498.78

return (12m)

p/e

12.41

p/bv

-28.31

DIVIDEND YIELD

0.80%

HCA price

HCA Healthcare

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment HCA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals HCA

Valuation

P/E

12.41

Sector -2.34

Industry 11.10

P/BV

-28.31

Sector 2.17

Industry 3.33

P/Revenue (PSR)

1.10

Sector 2.00

Industry 1.71

EV/EBITDA

32.33

Sector -23.69

Industry -398.52

EV/EBIT

42.80

Sector -36.60

Industry -80.73

P/EBITDA

5.38

Sector -0.10

Industry 8.30

P/EBIT

6.98

Sector -2.08

Industry 5.69

P/Total Assets

1.37

Sector 1.18

Industry 1.57

P/Net Current Assets

-1.74

Sector -10.91

Industry -3.38

P/Working Capital

-26.30

Sector 0.09

Industry 10.51

EPS

30.33

Sector -0.93

Industry 1.10

BVPS

-13.29

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

41.61%

Sector 44.28%

Industry 29.23%

EBITDA Margin

19.89%

Sector -291.45%

Industry 4.29%

EBIT Margin

15.02%

Sector -195.44%

Industry 1.44%

Operating Margin

15.67%

Sector -25.72%

Industry 2.16%

Net Profit Margins

8.89%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.31

Sector 0.12

Industry 0.27

Profitability

ROE

-228.14%

Sector -34.71%

Industry 6.97%

ROA

11.06%

Sector -28.76%

Industry 2.97%

ROIC

17.70%

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

0.80%

Sector -

Industry 0.01%

Payout

9.93%

Sector -

Industry 0.54%

Debt

Current Ratio

0.83

Sector 1.87

Industry 1.51

Net Debt / EBITDA

10.14

Sector -2.18

Industry -1.68

Net Debt / EBIT

13.43

Sector -0.74

Industry -7.00

Net Debt / Equity

-12.95

Sector -0.34

Industry 0.05

Gross Debt / Equity

-13.26

Sector -0.64

Industry 0.35

Equity/Assets

-0.05

Sector 0.43

Industry 0.46

Liabilities/Assets

1.05

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

5.39%

Sector -

Industry -

5Y Earnings CAGR

-0.47%

Sector -

Industry -

Fundamentals HCA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
HCA HCA Healthcare Inc.	$498.78	50.64%	0.80%	12.41	-28.31	-228.14%	8.89%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

HCA Historical Dividends

current DY: 0.80%

5-year average DY: 0.81%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/17/2026	03/31/2026	0.78000000
Dividends	12/15/2025	12/29/2025	0.72000000
Dividends	09/16/2025	09/30/2025	0.72000000
Dividends	06/16/2025	06/30/2025	0.72000000
Dividends	03/17/2025	03/31/2025	0.72000000
Dividends	12/13/2024	12/27/2024	0.66000000
Dividends	09/16/2024	09/30/2024	0.66000000
Dividends	06/14/2024	06/28/2024	0.66000000
Dividends	03/15/2024	03/29/2024	0.66000000
Dividends	12/14/2023	12/28/2023	0.60000000
Dividends	09/15/2023	09/29/2023	0.60000000
Dividends	06/16/2023	06/30/2023	0.60000000
Dividends	03/17/2023	03/31/2023	0.60000000
Dividends	12/14/2022	12/28/2022	0.56000000
Dividends	09/16/2022	09/30/2022	0.56000000
Dividends	06/16/2022	06/30/2022	0.56000000
Dividends	03/17/2022	03/31/2022	0.56000000
Dividends	12/14/2021	12/29/2021	0.48000000
Dividends	09/16/2021	09/30/2021	0.48000000
Dividends	06/16/2021	06/30/2021	0.70000000
Dividends	03/17/2021	03/31/2021	0.48000000
Dividends	12/31/2020	01/13/2021	0.26780000
Dividends	10/30/2020	11/12/2020	0.07200000
Dividends	03/02/2020	03/31/2020	0.43000000
Dividends	12/02/2019	12/27/2019	0.40000000
Dividends	09/03/2019	09/30/2019	0.40000000
Dividends	06/03/2019	06/28/2019	0.40000000
Dividends	03/01/2019	03/29/2019	0.40000000
Dividends	12/03/2018	12/28/2018	0.35000000
Dividends	09/04/2018	09/28/2018	0.35000000
Dividends	06/01/2018	06/29/2018	0.35000000
Dividends	03/01/2018	03/30/2018	0.35000000
Dividends	12/17/2012	12/21/2012	2.00000000
Dividends	11/02/2012	11/16/2012	2.50000000
Dividends	02/16/2012	02/29/2012	2.00000000

ABOUT HCA Healthcare

HCA Healthcare Inc.

Average Investor10 user rating

4.0 (0 people)

States of America

16 years

Founded: 2010

2011

Time since IPO - 15 years

280.000

Employees

HCA Healthcare Inc. (States of America) is listed on the NYSE and has a market capitalization of $84.32 billion, with shareholders equity totaling $-2.98 billion.

The company employs approximately 280.000 people and operates in the Saúde sector, within the Serviços e Fornecedores de Saúde industry.

Over the past 12 months, HCA Healthcare Inc. reported $76.39 billion in revenue, generating net income of $6.79 billion.

Key financial metrics include a P/E ratio of 12.41, a price-to-book (P/B) ratio of -28.31, and a trailing twelve-month dividend yield of 0.80%.

The company trades under the ticker HCA.

Market cap

$84.32 billion

Net worth

$-2.98 billion

$-2,978,000,000.00

Assets

$61.45 billion

$61,450,000,000.00

Total Shares Outstanding

224.00 million

224,000,000

Average Daily Trading Volume

$1.71 million

$1,708,794.54

Sector

Saúde

Industry

Serviços e Fornecedores de Saúde

HCA

revenue by Business Segment HCA Healthcare

HCA revenue and profits

Financial Results HCA

DRAG THE FRAME TO SEE MORE DATA

HCA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56

ABT - Abbott

$101.06 --18,39% (12M)

P/E

25.64

0.00%

ROE

12.06%

P/BV

3.09